Turnstone Biologics (TSBX) Competitors $0.37 -0.01 (-2.32%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSBX vs. FGEN, ALXO, CVKD, OSTX, IRD, TPST, ESLA, RVPH, XCUR, and NRXPShould you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include FibroGen (FGEN), ALX Oncology (ALXO), Cadrenal Therapeutics (CVKD), OS Therapies (OSTX), Opus Genetics (IRD), Tempest Therapeutics (TPST), Estrella Immunopharma (ESLA), Reviva Pharmaceuticals (RVPH), Exicure (XCUR), and NRx Pharmaceuticals (NRXP). These companies are all part of the "pharmaceutical products" industry. Turnstone Biologics vs. FibroGen ALX Oncology Cadrenal Therapeutics OS Therapies Opus Genetics Tempest Therapeutics Estrella Immunopharma Reviva Pharmaceuticals Exicure NRx Pharmaceuticals FibroGen (NASDAQ:FGEN) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Does the MarketBeat Community prefer FGEN or TSBX? FibroGen received 342 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 59.45% of users gave FibroGen an outperform vote while only 44.44% of users gave Turnstone Biologics an outperform vote. CompanyUnderperformOutperformFibroGenOutperform Votes34659.45% Underperform Votes23640.55% Turnstone BiologicsOutperform Votes444.44% Underperform Votes555.56% Do institutionals and insiders hold more shares of FGEN or TSBX? 72.7% of FibroGen shares are held by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are held by institutional investors. 2.0% of FibroGen shares are held by company insiders. Comparatively, 32.1% of Turnstone Biologics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer FGEN or TSBX? In the previous week, FibroGen had 1 more articles in the media than Turnstone Biologics. MarketBeat recorded 8 mentions for FibroGen and 7 mentions for Turnstone Biologics. Turnstone Biologics' average media sentiment score of 0.88 beat FibroGen's score of 0.27 indicating that Turnstone Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FibroGen 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Turnstone Biologics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, FGEN or TSBX? Turnstone Biologics has lower revenue, but higher earnings than FibroGen. FibroGen is trading at a lower price-to-earnings ratio than Turnstone Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFibroGen$29.62M1.00-$284.23M-$0.48-0.61Turnstone Biologics$19.31M0.44-$55.20M-$3.24-0.11 Do analysts prefer FGEN or TSBX? FibroGen presently has a consensus target price of $10.00, indicating a potential upside of 3,312.97%. Turnstone Biologics has a consensus target price of $0.45, indicating a potential upside of 22.62%. Given FibroGen's stronger consensus rating and higher possible upside, research analysts clearly believe FibroGen is more favorable than Turnstone Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FibroGen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Turnstone Biologics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Is FGEN or TSBX more profitable? Turnstone Biologics has a net margin of 0.00% compared to FibroGen's net margin of -67.66%. FibroGen's return on equity of 0.00% beat Turnstone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets FibroGen-67.66% N/A -36.17% Turnstone Biologics N/A -105.99%-87.27% Which has more risk & volatility, FGEN or TSBX? FibroGen has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. SummaryFibroGen beats Turnstone Biologics on 12 of the 18 factors compared between the two stocks. Remove Ads Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSBX vs. The Competition Export to ExcelMetricTurnstone BiologicsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.49M$2.96B$5.55B$7.50BDividend YieldN/A1.53%5.35%4.04%P/E Ratio-0.1130.4022.9418.10Price / Sales0.44382.94361.5886.56Price / CashN/A168.6838.1634.64Price / Book0.093.646.494.00Net Income-$55.20M-$72.06M$3.21B$247.18M7 Day Performance-10.03%-10.40%-6.28%-6.34%1 Month Performance3.38%-16.62%-0.55%-7.34%1 Year Performance-87.47%-30.49%6.18%-4.21% Turnstone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSBXTurnstone Biologics1.8943 of 5 stars$0.37-3.4%$0.45+22.6%-86.9%$8.49M$19.31M-0.1182Earnings ReportAnalyst RevisionFGENFibroGen4.396 of 5 stars$0.37+17.1%$10.00+2,610.0%-85.8%$37.24M$29.62M-0.30570Analyst ForecastAnalyst RevisionNews CoverageGap DownALXOALX Oncology3.3405 of 5 stars$0.69-2.4%$4.14+499.7%-94.4%$36.85MN/A-0.2340Gap DownCVKDCadrenal Therapeutics2.5029 of 5 stars$19.50+0.7%$32.00+64.1%N/A$36.66MN/A-2.924Analyst RevisionOSTXOS Therapies1.9565 of 5 stars$1.68-2.9%$17.50+941.7%N/A$36.57MN/A0.00N/AAnalyst ForecastNews CoverageGap DownIRDOpus Genetics1.9866 of 5 stars$1.15-8.7%$8.00+595.7%N/A$36.30M$8.38M-1.0614Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeTPSTTempest Therapeutics2.9872 of 5 stars$0.83+0.4%$26.00+3,051.5%-85.1%$36.01MN/A-0.5420Earnings ReportShort Interest ↓Analyst RevisionGap DownESLAEstrella Immunopharma2.0186 of 5 stars$0.99-2.0%$16.00+1,516.5%-34.1%$35.81MN/A-3.81N/AGap DownRVPHReviva Pharmaceuticals3.9731 of 5 stars$1.07+2.9%$11.40+965.4%-83.8%$35.78MN/A-0.965Earnings ReportAnalyst ForecastNews CoverageXCURExicure1.4176 of 5 stars$13.57-3.4%N/A+1,907.5%$35.36M$500,000.00-6.5650NRXPNRx Pharmaceuticals2.6532 of 5 stars$2.07-0.5%$31.67+1,429.8%-59.8%$35.02MN/A-0.972Analyst ForecastNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies FibroGen Competitors ALX Oncology Competitors Cadrenal Therapeutics Competitors OS Therapies Competitors Opus Genetics Competitors Tempest Therapeutics Competitors Estrella Immunopharma Competitors Reviva Pharmaceuticals Competitors Exicure Competitors NRx Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSBX) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TSBX Stock Free TSBX Stock Alerts